Bookby Jasna Mihailovic, Stanley J. Goldsmith, Ronan P. Killeen.
Summary: FDG PET/CT has rapidly emerged as an invaluable combined imaging modality that can identify tumors on the basis of not only anatomical alterations but also metabolic activity, thus allowing the detection of lesions that would otherwise be too small to distinguish. This book, comprising a collection of images from oncology cases, is organized according to the role of FDG PET/CT in the evaluation and management of oncology patients, and only secondarily by organ or tumor entity. In this way, it reflects the issues that clinicians actually address in their daily practice, namely: identification of an unknown or unsuspected primary; determination of the extent of disease; evaluation of response to therapy; and surveillance after response, i.e., detection of recurrent disease. In total, 100 cases involving different primary tumors are presented to illustrate findings in these different circumstances. FDG PET/CT in Clinical Oncology will be of great value to all newcomers to this field, whether medical students, radiology, nuclear medicine, or oncology fellows, or practicing physicians.
Contents:
Pt. I. Diagnosis
1. Solitary Pulmonary Nodule (SPN), Chest Mass
2. Unknown Primary
3. Unexpected Malignancy/Second Primary
pt. II. Extent of disease
4. Head and Neck Carcinoma
5. Lung Carcinoma
6. Breast Carcinoma
7. Esophageal Carcinoma
8. Colorectal Carcinoma
9. Lymphoma
10. Multiple Myeloma
11. Gynecological Adenocarcinomata --12. Miscellaneous Malignancies
pt. III Follow-up
13. Head and Neck
14. Lung Carcinoma
15. Breast Carcinoma
16. Pancreas Carcinoma
17. Colorectal Carcinoma
18. Lymphoma
19. Multiple Myeloma
20. Thyroid Gland
21. Urologic Tumors Bladder
22. Miscellaneous
pt. IV Response to treatment
23. Lymphoma
24. Multiple Myeloma
25. Lung
26. Gastrointestinal Tumors
27. Breast
28. Neuroendocrine Tumor
pt. V.Neuro Section
29. Brain Tumors.